Immune-Related Thyroid Adverse Events Predict Response to PD-1 Blockade in Patients with Melanoma

SIMPLE SUMMARY: We evaluated the immune-related thyroid adverse events (irTAEs) during anti-PD-1 therapy in terms of their influence on overall survival (OS) rates in melanoma. Based on data from 249 patients with metastatic melanoma and a normal thyroid stimulating hormone (TSH) at baseline, we fou...

Descripción completa

Detalles Bibliográficos
Autores principales: Dawidowska, Anna, Jagodzinska-Mucha, Paulina, Koseła-Paterczyk, Hanna, Jaczewska, Sylwia, Sobczuk, Paweł, Chelstowska, Monika, Kowalska, Maria, Badziak-Sterczewska, Honorata, Poleszczuk, Jan, Rutkowski, Piotr, Lugowska, Iwona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909092/
https://www.ncbi.nlm.nih.gov/pubmed/35267557
http://dx.doi.org/10.3390/cancers14051248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909092/
https://www.ncbi.nlm.nih.gov/pubmed/35267557
http://dx.doi.org/10.3390/cancers14051248

Ejemplares similares